In: Molecular oncology, 2015, vol. 9, no. 6, p. 1194-1206
STAT3 is a key element in many oncogenic pathways and, like other transcription factors, is an attractive target for development of novel anticancer drugs. However, interfering with STAT3 functions has been a difficult task and very few small molecule inhibitors have made their way to the clinic. OPB‐31121, an anticancer compound currently in clinical trials, has been reported to affect...
|
In: Proceedings of the national academy of sciences of the United States of America, 2017, vol. 114, no. 25, p. E4924-E4933
In addition to its canonical role in nuclear transcription, signal transducer and activator of transcription 3 (STAT3) is emerging as an important regulator of mitochondrial function. Here, we demonstrate that a novel inhibitor that binds with high affinity to the STAT3 SH2 domain triggers a complex cascade of events initiated by interference with mitochondrial STAT3 (mSTAT3). The...
|
Thèse de doctorat : Université de Fribourg, 2000 ; nr. 1321.
L’apoptose (ou mort cellulaire programmée) est un processus cellulaire essentiel présent dans la majorité des organismes. Afin de préserver l’homéostase des tissus, un nombre comparable de cellules doit mourir pour maintenir l'équilibre avec les cellules produites par mitose. Cependant, dans de nombreuses maladies (en particulier le cancer), ce méchanisme de mort cellulaire est...
|